Shaanxi Meibang Pharmaceutical Group Co Ltd (605033) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.246x

Based on the latest financial reports, Shaanxi Meibang Pharmaceutical Group Co Ltd (605033) has a cash flow conversion efficiency ratio of 0.246x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥281.88 Million ≈ $41.25 Million USD) by net assets (CN¥1.15 Billion ≈ $167.89 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Shaanxi Meibang Pharmaceutical Group Co Ltd - Cash Flow Conversion Efficiency Trend (2017–2024)

This chart illustrates how Shaanxi Meibang Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of Shaanxi Meibang Pharmaceutical Group Co for a breakdown of total debt and financial obligations.

Shaanxi Meibang Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shaanxi Meibang Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Advanced Power Electronics Corp TW:8261	-0.011x
Medy-Tox Inc KQ:086900	0.041x
Schoeller-Bleckmann Oilfield Equipment Aktiengesellschaft VI:SBO	0.045x
JiangXi BaiSheng Intelligent Technology Co. Ltd. SHE:301083	N/A
Liaoning He Eye Hospital Group Co. LTD. SHE:301103	N/A
Boiron SA PA:BOI	0.076x
Daodaoquan Grain and Oil Co Ltd SHE:002852	0.035x
I-Mab NASDAQ:IMAB	0.007x

Annual Cash Flow Conversion Efficiency for Shaanxi Meibang Pharmaceutical Group Co Ltd (2017–2024)

The table below shows the annual cash flow conversion efficiency of Shaanxi Meibang Pharmaceutical Group Co Ltd from 2017 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Shaanxi Meibang Pharmaceutical Group Co worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥1.12 Billion ≈ $164.57 Million	CN¥280.40 Million ≈ $41.03 Million	0.249x	-17.03%
2023-12-31	CN¥1.11 Billion ≈ $163.04 Million	CN¥334.79 Million ≈ $48.99 Million	0.300x	+158.23%
2022-12-31	CN¥1.09 Billion ≈ $158.97 Million	CN¥126.41 Million ≈ $18.50 Million	0.116x	+203.46%
2021-12-31	CN¥966.95 Million ≈ $141.50 Million	CN¥-108.75 Million ≈ $-15.91 Million	-0.112x	-167.50%
2020-12-31	CN¥449.37 Million ≈ $65.76 Million	CN¥74.88 Million ≈ $10.96 Million	0.167x	-51.92%
2019-12-31	CN¥370.63 Million ≈ $54.24 Million	CN¥128.45 Million ≈ $18.80 Million	0.347x	+464.79%
2018-12-31	CN¥276.37 Million ≈ $40.44 Million	CN¥16.96 Million ≈ $2.48 Million	0.061x	-62.35%
2017-12-31	CN¥180.43 Million ≈ $26.40 Million	CN¥29.41 Million ≈ $4.30 Million	0.163x	--

About Shaanxi Meibang Pharmaceutical Group Co Ltd

SHG:605033 China Agricultural Inputs

Market Cap

$456.81 Million

CN¥3.12 Billion CNY

Market Cap Rank

#13053 Global

#4094 in China

Share Price

CN¥23.09

Change (1 day)

-0.65%

52-Week Range

CN¥16.93 - CN¥31.54

All Time High

CN¥31.54